HomeREGN • NASDAQ
add
Regeneron Pharmaceuticals Inc
$741.92
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$741.92
Sarado: Ene 15, 4:06:01 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$754.14
Sakop ng araw
$737.00 - $756.50
Sakop ng taon
$476.49 - $821.11
Market cap
77.98B USD
Average na Volume
881.37K
P/E ratio
17.76
Dividend yield
0.47%
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 3.75B | 0.90% |
Gastos sa pagpapatakbo | 647.80M | -9.32% |
Net na kita | 1.46B | 8.91% |
Net profit margin | 38.89 | 7.94% |
Kita sa bawat share | 11.83 | -5.06% |
EBITDA | 1.25B | -8.70% |
Aktuwal na % ng binabayarang buwis | 17.20% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 8.44B | -13.81% |
Kabuuang asset | 40.17B | 7.28% |
Kabuuang sagutin | 9.21B | 13.50% |
Kabuuang equity | 30.96B | — |
Natitirang share | 102.60M | — |
Presyo para makapag-book | 2.50 | — |
Return on assets | 7.08% | — |
Return on capital | 8.37% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.46B | 8.91% |
Cash mula sa mga operasyon | 1.62B | 25.36% |
Cash mula sa pag-invest | -402.90M | 29.86% |
Cash mula sa financing | -717.90M | -13.23% |
Net change in cash | 497.50M | 495.10% |
Malayang cash flow | 1.42B | 86.68% |
Tungkol
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Itinatag
1988
Headquarters
Website
Mga Empleyado
15,222
